Insmed (INSM) Return on Equity (2011 - 2026)

Insmed's Return on Equity history runs 16 years deep, the most recent figure standing at 0.02% for Q1 2026.

• In Q1 2026, Return on Equity rose 4.0% year-over-year to 0.02%; the TTM figure through Mar 2026 stood at 0.02% (up 4.0% YoY), while the FY2025 annual figure was 0.02%, down 42.0% from the prior year.
• Return on Equity was 0.02% for Q1 2026 at Insmed, down from 0.02% in the prior quarter.
• In the past five years, Return on Equity ranged from a high of 0.07% in Q2 2023 to a low of 0.61% in Q3 2022.
• Historically, Return on Equity has averaged 0.06% across 5 years, with a median of 0.02% in 2026.
• The sharpest annual moves came in 2022 and 2023: Return on Equity sank 60 bps in 2022, then jumped 64 bps in 2023.
• A 5-year view of Return on Equity shows it stood at 0.17% in 2022, then soared by 115 bps to 0.02% in 2023, then plunged by 199 bps to 0.02% in 2024, then surged by 36 bps to 0.02% in 2025, then fell by 8 bps to 0.02% in 2026.
• The last three Return on Equity figures came in at 0.02% (Q1 2026), 0.02% (Q4 2025), and 0.01% (Q3 2025), per Business Quant data.